by Home

Managing Your Chronic Kidney Disease - Taking Control of Phosphorus


Managing Your Chronic Kidney Disease - Taking Control of Phosphorus

Topic: Nephrology
Relevant Terms: Chronic Kidney Disease
Primary Audience: Individuals with Chronic Kidney Disease
Launch Date: 29-Jan-16
Expiration Date: The accreditation for this activity has expired.
Curriculum Name: Management of Chronic Kidney Disease (CKD)

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Learn how excessive phosphorus intake may worsen your chronic kidney disease
  2. Identify ways to lower your phosphorus level through your diet and by taking medication
    Jane S. Davis, CRNP, DNP
    Division of Nephrology
    University of Alabama at Birmingham
    Birmingham, AL
    This activity is supported by an educational grant from sanofi-aventis U.S.
    Upon completion of the activity, you will receive a certificate of participation which you can share with your healthcare professional.
    This activity is designed to assist individuals with chronic kidney disease to manage their condition. It is not meant to provide medical advice, and the content of this activity is not a substitute for the advice and medical opinion of a licensed healthcare professional. Please consult with your clinician before attempting any new health practice. The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy.
    Your use of these services is at your own risk. By participating, you agree to release and hold us harmless from any harm caused by your reliance on material provided through this activity, and you assume all liability for outcomes based thereon.
    If you have a medical emergency, call your healthcare professions, 911, or your local emergency services immediately.
    According to the disclosure policy of the Academy, all those who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence. 
    Jane S. Davis, CRNP, DNP, reports no relevant relationships with any commercial interests.
    Tom Nickolas, MD, MS, Associate Professor of Clinical Medicine, Columbia University Medical Center, discloses the following relationships: Advisory Board (for scientific information): Merck, Celgene; Intellectual Property/Patents: Columbia University has licensed patents for the use of NGAL as a marker of acute kidney injury
    Planning Committee
    Paul J. Miniter, MS, Beth Paczolt, MD, and John JD Juchniewicz, MCIS, CHCP, American Academy of CME, Inc., report no relevant relationships with any commercial interests.
    There will be no discussion of non-FDA approved uses of products within this activity.
    Supported Browsers:
    Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
    Google Chrome 28.0+ for Windows, Mac OS, or Linux
    Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
    Safari 5.0+ for Mac OSX 10.5 and above
    Supported Phones & Tablets:
    Android 4.0.3 and above
    iPhone/iPad with iOS 6.1 or above